Meta-analysis of multi-center transcriptomic profiles and machine learning reveal phospholipase Cβ4 as a Wnt/Ca²<sup>+</sup> signaling mediator in glioblastoma immunotherapy.

Front Immunol · 2025 · PMC12368592 · PMID 40852729

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

In contrast, APCDD1, THRA, and PLCB4 were downregulated, while ITPRIPL1 exhibited an increasing trend ( Figure 2D ).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Meta-analysis of multi-center transcriptomic profiles and machine learning reveal phospholipase Cβ4 as a Wnt/Ca²&lt;sup&gt;+&lt;/sup&gt; signaling mediator in glioblastoma immunotherapy.

The sentences

Meta-analysis of multi-center transcriptomic profiles and machine learning reveal phospholipase Cβ4 as a Wnt/Ca²<sup>+</sup> signaling mediator in glioblastoma immunotherapy.